Cyclodextrin keeps the head on non-alcoholic beer
When cyclodextrin meets brewer’s yeast Non-alcoholic beer sales keep growing, but one complaint remains: the foam collapses too fast. Without
Tag: patent
Technological trends in cyclodextrin inclusion complexes for improving cardiovascular drug therapy: A patent review,
Cardiovascular diseases are disorders that compromise the heart and circulatory systems. Ischemic heart disease is one of the causes of
Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó
This year’s Nobel Prize in physiology or medicine has been awarded to Katalin Karikó and Drew Weissman for their work
Antibacterial drugs and cyclodextrin inclusion complexes: a patent review
The patents analyzed in the review used treatments based on antibiotics already on the market, natural products, and synthesized molecules
New US patent for SBECD purification by CycloLab
The status of US patent application 17/344,217 (“Purification of sulfobutylated cyclodextrins with specific ion exchange resins” by CycloLab, Hungary) was
MIT scientists filed patent for HPBCD treatment in Alzheimer’s disease
Li-Huei Tsai, director of Picower Institute for Learning and Memory (Massachusetts Institute of Technology) and her coworkers recently filed a patent
New US patent application on ternary CD/small guest molecule/protein interactions
Cyclolab Ltd filed a patent application (US20220282001) on cyclodextrin containing physical mixtures and inclusion complexes that show improved protein stabilizing
Cyclodextrin for treating lymphedema
A recent patent application of NATIONAL UNIVERSITY OF SINGAPORE claims for the treatment of lymphedema by using empty cyclodextrin (beta-cyclodextrin
METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS INFECTIONS SUCH AS SARS-CoV-2
The patent application (1) with priority date of 09. March 2020 claims that methyl bCD preferably with DS 0.7 (Crysmeb)
European Patent Office upholds Curadev’s SBE-β-CD patent for new composition of matter
Yahoo Finance published: Working with Professor Steve Wicks and his team at the University of Greenwich, Curadev developed a new method for